?? |
?? ?? |
CAS |
MF |
|
IPI 145 |
1201438-56-3 |
C22H17ClN6O |
|
PIK-93 |
593960-11-3 |
C14H16ClN3O4S2 |
|
6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide |
371942-69-7 |
C25H21N7O3 |
|
PF-05212384 |
1197160-78-3 |
C32H41N9O4 |
|
GSK2636771 |
1372540-25-4 |
C22H22F3N3O3 |
|
?????? |
107-15-3 |
C2H8N2 |
|
?????? |
446-86-6 |
C9H7N7O2S |
|
NAFAMOSTAT MESYLATE |
81525-10-2 |
C19H17N5O2 |
|
[4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone(R 547) |
741713-40-6 |
C18H21F2N5O4S |
|
FLAVOPIRIDOL HYDROCHLORIDE |
131740-09-5 |
C21H21Cl2NO5 |
|
PHA-793887 |
718630-59-2 |
C19H31N5O2 |
|
JNJ-7706621 |
443797-96-4 |
C15H12F2N6O3S |
|
OSI-027 |
936890-98-1 |
C21H22N6O3 |
|
42-(Dimethylphosphinate)rapamycin |
572924-54-0 |
C53H84NO14P |
|
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide |
1009298-59-2 |
C25H30N6O3 |
|
????529(P529) |
914913-88-5 |
C24H22O6 |
|
(2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol |
1380288-87-8 |
C30H42N8O3 |
|
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
1346574-57-9 |
C31H38N6O2 |
|
PHA-680632 |
398493-79-3 |
C28H35N7O2 |
|
AT9283 |
896466-04-9 |
C19H23N7O2 |
|
BIX 02188 |
1094614-84-2 |
C25H24N4O2 |
|
MC1568 |
852475-26-4 |
C17H15FN2O3 |
|
?????? |
888216-25-9 |
C20H20N4O3 |
|
M344 |
251456-60-7 |
C16H25N3O3 |
|
CUDC-101 |
1012054-59-9 |
C24H26N4O4 |
|
CRA-02478 |
783355-60-2 |
C21H23N3O5 |
|
Luminespib |
747412-49-3 |
C26H31N3O5 |
|
NVP-BEP800 |
847559-80-2 |
C21H23Cl2N5O2S |
|
LDN-193189 |
1062368-24-4 |
C25H22N6 |
|
AT7867 |
857531-00-1 |
C20H20ClN3 |
|
GSK-3BETA INHIBITOR XII |
601514-19-6 |
C18H14N4O2 |
|
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone |
128517-07-7 |
C24H36N4O6S2 |
|
6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline |
356559-20-1 |
C21H21N5 |
|
Pracinostat |
929016-96-6 |
C20H30N4O2 |
|
XL019 |
945755-56-6 |
C25H28N6O2 |
|
17-DMAG |
467214-21-7 |
C32H49ClN4O8 |
|
ALK5 inhibitor II |
446859-33-2 |
C17H13N5 |
|
LY-364947 |
396129-53-6 |
C17H12N4 |
|
GSK1070916 |
942918-07-2 |
C30H33N7O |
|
A-966492 |
934162-61-5 |
C18H17FN4O |
|
LY 2784544 |
1229236-86-5 |
C23H25ClFN7O |
|
SB271046 |
209481-20-9 |
C20H22ClN3O3S2 |
|
GDC-0068 |
1001264-89-6 |
C24H32ClN5O2 |
|
RVX-208 |
1044870-39-4 |
C20H22N2O5 |
|
BIO |
667463-62-9 |
C16H10BrN3O2 |
|
BIIB-021 |
848695-25-0 |
C14H15ClN6O |
|
4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE |
327036-89-5 |
C10H10N2O2S |
|
Baricitinib |
1187594-09-7 |
C16H17N7O2S |
|
ACY-1215 |
1316214-52-4 |
C24H27N5O3 |
|
ZM 447439 |
331771-20-1 |
C29H31N5O4 |
|
PJ-34 |
344458-15-7 |
C17H17N3O2HCl |
|
AZD 1480 |
935666-88-9 |
C14H14ClFN8 |
|
I-BET151 (GSK1210151A) |
1300031-49-5 |
C23H21N5O3 |
|
AR-A014418 |
487021-52-3 |
C12H12N4O4S |
|
GW5074 |
220904-83-6 |
C15H8Br2INO2 |
|
Desvenlafaxine succinate |
386750-22-7 |
C20H31NO6 |
|
TW-37 |
877877-35-5 |
C33H35NO6S |
|
cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid |
471905-41-6 |
C21H21ClF2O4S |
|
??? |
873857-62-6 |
C52H74Cl2O18 |
|
SUCCINYLCHOLINE CHLORIDE DIHYDRATE |
6101-15-1 |
C14H34Cl2N2O6 |
|
2,2-DIPHENYL-N-(2,2,2-TRICHLORO-1-[3-(4-FLUORO-3-NITROPHENYL)THIOUREIDO]ETHYL)ACETAMIDE |
905973-89-9 |
C23H18Cl3FN4O3S |
|
Bromfenac sodium |
91714-93-1 |
C15H11BrNNaO3 |
|
DIBENZAZEPINE |
209984-56-5 |
C26H23F2N3O3 |
|
(R)-5-HydroxyMethyl Tolterodine |
207679-81-0 |
C22H31NO2 |
|
Volasertib (BI 6727) |
755038-65-4 |
C34H50N8O3 |
|
GO 6976 |
136194-77-9 |
C24H18N4O |
|
LONAFARNIB |
193275-84-2 |
C27H31Br2ClN4O2 |
|
5-(4-?????)-??-2-?????3,5-????????? |
944261-79-4 |
C19H16ClNO4 |
|
Sitaxentan sodium |
210421-74-2 |
C18H14ClN2NaO6S2 |
|
Avagacestat (BMS-708163) |
1146699-66-2 |
C20H17ClF4N4O4S |
|
IOX2 |
931398-72-0 |
C19H16N2O5 |
|
Avasimibe |
166518-60-1 |
C29H43NO4S |
|
bupivacaine hydrochloride |
18010-40-7 |
C18H28N2O.ClH |
|
PF 573228 |
869288-64-2 |
C22H20F3N5O3S |
|
DGAT-1 inhibitor |
959122-11-3 |
C26H24N2O4 |
|
5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime |
405554-55-4 |
C27H27N5O2 |
|
Prucalopride Succinate |
179474-85-2 |
C22H32ClN3O7 |
|
CEP-18770 |
847499-27-8 |
C21H28BN3O5 |
|
CALPEPTIN |
117591-20-5 |
C20H30N2O4 |
|
GNF-2 |
778270-11-4 |
C18H13F3N4O2 |
|
MK-0822 |
603139-19-1 |
C25H27F4N3O3S |
|
??????? |
901119-35-5 |
C23H26FN6O9P |
|
SB 743921 |
940929-33-9 |
C31H34Cl2N2O3 |
|
3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide |
1232410-49-9 |
C18H16N4O3S |
|
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide |
1355326-35-0 |
C27H31FN4O2 |
|
Tipifarnib |
192185-72-1 |
C27H22Cl2N4O |
|
Calpain Inhibitor I |
110044-82-1 |
C20H37N3O4 |
|
(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid |
1072833-77-2 |
C14H19BCl2N2O4 |
|
Cobicistat |
1004316-88-4 |
C40H53N7O5S2 |
|
?????? |
1257044-40-8 |
C45H50ClN7O7S |
|
TCID |
30675-13-9 |
C9H2Cl4O2 |
|
Epothilone A |
152044-53-6 |
C26H39NO6S |
|
Indacaterol Maleate |
753498-25-8 |
C24H28N2O3.C4H4O4 |
|
BMY 7378 DIHYDROCHLORIDE |
21102-95-4 |
C22H32ClN3O3 |
|
MLN9708 |
1201902-80-8 |
C20H23BCl2N2O9 |
|
PR-619 |
2645-32-1 |
C7H5N5S2 |
|
2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide |
587841-73-4 |
C21H19BrClN5O4S2 |
|
BLASTICIDIN S HYDROCHLORIDE |
3513-03-9 |
C17H27ClN8O5 |
|
RAF265(CHIR-265) |
927880-90-8 |
C24H16F6N6O |
|
AZD-4547 |
1035270-39-3 |
C26H33N5O3 |